Skip to main content

Solventum Corp income statement

  • SOLV · NYSE
  • Medical devices
  • Health Care Technology
  • S&P 500
$89.08+0.30%Close 13 Nov 2026

Solventum Corp reported revenue of $8.32 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 0.9% from fiscal 2024. Net income was $1.56 billion and diluted earnings per share $8.88.

From Solventum Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Solventum Corp income statement, annual
USDFY 2022FY 2023FY 2024FY 2025TTM
Revenue$8.13B$8.20B$8.25B$8.32B$8.16B
Revenue growth—+0.8%+0.7%+0.9%—
Net interest income$0.00$0.00−$367.0M−$347.0M−$245.0M
Gross profit$4.70B$4.69B$4.59B$4.45B$4.47B
Gross margin57.7%57.3%55.6%53.5%54.8%
Research and development$767.0M$758.0M$775.0M$739.0M$723.0M
Selling, general and administrative$2.23B$2.30B$2.78B$3.08B$3.33B
Operating expenses$3.00B$3.00B$3.56B——
Operating income$1.69B$1.69B$1.04B$2.18B$454.0M
Operating margin20.8%20.6%12.6%26.2%5.6%
Income before tax$1.69B$1.67B$605.0M$1.71B$171.0M
Income tax expense$349.0M$321.0M$127.0M$157.0M$14.00M
Effective tax rate20.6%19.3%21.0%9.2%8.2%
Net income$1.34B$1.35B$479.0M$1.56B$156.0M
Net margin16.5%16.4%5.8%18.7%1.9%
EPS · diluted$7.78$7.79$2.76$8.88$0.90
Diluted weighted average shares173M173M174M175M174M
Basic weighted average shares173M173M173M174M173M
EBITDA$2.27B$2.25B$1.59B$2.67B$975.0M
EBITDA margin27.9%27.5%19.3%32.1%11.9%
Depreciation & amortization$578.0M$561.0M$555.0M$489.0M$521.0M
Stock-based compensation$37.00M$39.00M$112.0M$161.0M$168.0M

Quarterly

Solventum Corp income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$2.04B$2.02B$2.08B$2.08B$2.08B$2.07B$2.16B$2.10B$2.00B$2.01B$2.21B$1.95B
Net interest income$0.00−$39.00M−$114.0M−$107.0M−$107.0M−$104.0M−$103.0M−$89.00M−$51.00M−$62.00M−$64.00M−$68.00M
Gross profit$1.16B$1.17B$1.14B$1.17B$1.12B$1.11B$1.18B$1.14B$1.03B$1.10B$1.29B$1.06B
Gross margin56.9%58.1%54.6%56.0%53.9%53.8%54.4%54.2%51.4%54.7%58.2%54.5%
Research and development$190.0M$195.0M$192.0M$189.0M$199.0M$193.0M$189.0M$183.0M$175.0M$189.0M$178.0M$181.0M
Selling, general and administrative$562.0M$596.0M$701.0M$701.0M$784.0M$769.0M$772.0M$780.0M$759.0M$827.0M$927.0M$813.0M
Operating expenses$752.0M$791.0M$893.0M$890.0M$983.0M$962.0M$961.0M——$1.02B$1.10B$994.0M
Operating income$406.0M$381.0M$244.0M$275.0M$136.0M$152.0M$214.0M$1.69B$124.0M$81.00M$181.0M$68.00M
Operating margin19.9%18.9%11.7%13.2%6.6%7.3%9.9%80.6%6.2%4.0%8.2%3.5%
Income before tax$391.0M$329.0M$96.00M$167.0M$13.00M$38.00M$103.0M$1.51B$58.00M$16.00M$108.0M−$11.00M
Income tax expense$119.0M$92.00M$7.00M$45.00M−$17.00M−$99.00M$13.00M$248.0M−$5.00M$3.00M$15.00M$1.00M
Effective tax rate30.4%28.0%7.3%26.9%−131%−261%12.6%16.4%−8.6%18.8%13.9%−9.1%
Net income$272.0M$237.0M$89.00M$122.0M$31.00M$137.0M$90.00M$1.27B$63.00M$13.00M$92.00M−$12.00M
Net margin13.4%11.8%4.3%5.9%1.5%6.6%4.2%60.4%3.2%0.6%4.2%−0.6%
EPS · diluted$1.57$1.37$0.51$0.70$0.18$0.78$0.51$7.22$0.36$0.07$0.53−$0.07
Diluted weighted average shares173M173M174M174M175M175M175M175M176M176M173M171M
Basic weighted average shares173M173M173M173M173M174M174M174M174M174M173M171M
EBITDA$545.0M$520.0M$377.0M$408.0M$286.0M$281.0M$336.0M$1.81B$241.0M$216.0M$314.0M$204.0M
EBITDA margin26.8%25.8%18.1%19.6%13.8%13.6%15.5%86.4%12.1%10.8%14.2%10.5%
Depreciation & amortization$139.0M$139.0M$133.0M$133.0M$150.0M$129.0M$122.0M$121.0M$117.0M$135.0M$133.0M$136.0M
Stock-based compensation$7.00M$4.00M$56.00M$27.00M$25.00M$49.00M$34.00M$41.00M$37.00M$51.00M$38.00M$42.00M

The main figures as JSON and plain text. See data and methodology.

SOLV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.